Clinical Trials Logo

Filter by:
NCT ID: NCT05817617 Recruiting - Clinical trials for Head and Neck Cancer

Vitamin D and Head and Neck Cancer: Impact on Toxicity and Prognosis

Start date: August 8, 2021
Phase:
Study type: Observational

The goal of this observational study is to learn about relation between vitamin D levels in subjects with head and neck cancer. The main question it aims to answer are: - variation of vitamin D levels in the study population at different time points - relation between therapy side effects and vitamin D level - relation between disease outcome and vitamin D level Participants will be followed as per clinical practice

NCT ID: NCT05817305 Recruiting - Clinical trials for Cardiovascular Diseases

Integrating Exercise Into Lifestyle of Cardiac Outpatients

ITER
Start date: January 1, 1997
Phase:
Study type: Observational [Patient Registry]

The purpose of the study is to investigate the long-term effects of a personalized physical activity program on exercise capacity and quality of life in patients with stable cardiovascular disease. The analysis also intends to evaluate the prognostic value of cardiovascular function estimated through a walking test (1km Treadmill Walking Test, 1k-TWT) in relation to survival, hospitalization, and medical costs. The program considers clinical, socio-economic, and behavioural aspects, psychological support, and risk factor control. Patients receive indications for carrying out a home training program based on the performance of moderate-intensity aerobic activity at least 3-4 days a week for at least 30-60 minutes a day. All patients are also encouraged to improve their daily habits by preferring a more active lifestyle both at home and at work.

NCT ID: NCT05817292 Completed - Vaginal Disease Clinical Trials

Study of the Vaginal Microbiota in Women Under Fertile Age

vaginalbiota
Start date: February 1, 2022
Phase:
Study type: Observational

Characterization of the vaginal microbiota of women under fertile age and study of correlations with gynecological disorders

NCT ID: NCT05817227 Recruiting - Breast Cancer Clinical Trials

Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.

Selebrec
Start date: May 19, 2022
Phase:
Study type: Observational

This is multicentric, spontaneous, observational, retrospective and prospective study.

NCT ID: NCT05817175 Recruiting - Breast Cancer Clinical Trials

International Prospective REgistry on Pre-pectorAl Breast REconstruction

I-PREPARE
Start date: October 16, 2023
Phase:
Study type: Observational

This is an international multicenter prospective cohort study aimed at collecting data on breast reconstruction techniques with pre-pectoral implants after mastectomy for breast cancer. The aim of the study is to collect data on the surgical, aesthetic and oncological results, as well as on the quality of life of the patients who will undergo breast reconstruction with a pre-pectoral approach.

NCT ID: NCT05817123 Completed - Clinical trials for Obstructive Sleep Apnea

Validation of the Mutuality Scale in Patients With OSA and Their Partners

VAMOS
Start date: May 10, 2021
Phase:
Study type: Observational

Main objective of this study is to assess the psychometric characteristics of the Mutuality Scale both in patients with Obstructive Sleep Apnea Syndrome (OSAS) and in their partners-The association between the mutuality score in OSAS patients and their adherence to the use of Continuous Positive Airway Pressure (CPAP) therapy will also be investigated. The results of the study may allow a validation of the Mutuality Score as an instrument for measuring mutuality between OSAS patients and their partners.

NCT ID: NCT05816954 Recruiting - Clinical trials for Acute Respiratory Distress Syndrome

Imaging Biomarkers to Stratify the Risk of Barotrauma in ARDS

FRAIL ARDS
Start date: August 30, 2023
Phase:
Study type: Observational

The high incidence of barotrauma in patients with COVID-19-related acute respiratory distress syndrome (ARDS) (16.1%, with a mortality rate >60%) provides rationale for considering COVID-19 ARDS a paradigm for lung frailty. The investigators recently discovered that the Macklin effect is an impressive radiological predictor of barotrauma in COVID-19 ARDS. Since lung frailty is a major issue also in non-COVID-19 ARDS (6% barotrauma, with a mortality rate of 46% ) the investigators want to confirm the importance of Macklin effect in non-COVID-19 ARDS. Using artificial intelligence-based approaches the investigators also want to identify imaging biomarkers to non-invasively assess lung frailty in a mixed cohort of COVID-19/non-COVID-19 ARDS patients. Furthermore, the investigators want to prospectively validate these biomarkers in a cohort of ARDS patients. This will provide a therapeutic algorithm for ARDS patients at high-risk for barotrauma, identifying those most likely to benefit from hyper protective strategies.

NCT ID: NCT05816850 Recruiting - Follicular Lymphoma Clinical Trials

Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial

FIL_FOLL-BIO
Start date: September 19, 2023
Phase:
Study type: Observational

This is a Multicenter, Retrospective, Biological study ancillary to FOLL12 trial to evaluate the role of EZH2 aberrations in patient with FL treated with immunochemotherapy. Moreover, several novel biomarkers of FL will be investigated.

NCT ID: NCT05816382 Recruiting - Narcolepsy Type 1 Clinical Trials

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

Start date: April 5, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The main aim is to evaluate the safety and tolerability of TAK-861 on participants with type 1 and type 2 narcolepsy from previous parent studies, TAK-861-2001 (NCT05687903) and TAK-861-2002 (NCT05687916).

NCT ID: NCT05816213 Not yet recruiting - Stroke Clinical Trials

Point-of-care Low-field MRI in Acute Stroke

POCS
Start date: September 1, 2023
Phase:
Study type: Observational

Consecutive patients accessing the emergency department with suspected stroke dispatch will be recruited at 3 study units: 1) ASL Abruzzo 1, hospitals of L'Aquila and Avezzano; 2) ASL Abruzzo 2, hospital of Chieti; 3) IRCCS Humanitas Research Hospital of Milan. Anonymized clinical and low-field (LF) MRI data as well as conventional neuroimaging data will be independently assessed by external units (Università Politecnica delle Marche and Policlinico di Messina, respectively). Both units will independently adjudicate the best treatment option, while the latter will also provide historical MRI data of stroke patients to develop artificial intelligence algorithms facilitating LF-MRI images interpretation (Libera Università di Bolzano). Agreement with conventional neuroimaging will be evaluated at different time points (hyperacute, acute -24 h, subacute -72 h, discharge, chronic -4 weeks). Further investigations will include feasibility study to develop an ambulance (mobile stroke unit) equipped with LF-MRI and cost-effectiveness analysis of LF-MRI. This trial will provide necessary data to validate the use of LF-MRI in the acute stroke care.